Arsil%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520dx

# Arsil 252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525 20dx ## Overview Arsil 20dx is a combination medication containing Arsenic trioxide and Dimercaprol. It is used in the treatment of acute promyelocytic leukemia (APL). ## Primary Indications * Treatment of newly diagnosed or relapsed/refractory acute promyelocytic leukemia (APL). ## Adult Dosing The dosing of Arsil 20dx is complex and typically involves a combination of Arsenic Trioxide and Dimercaprol, administered in specific cycles. The exact regimen depends on the phase of treatment (induction, consolidation, maintenance) and may be determined by institutional protocols. **Induction Phase (Example):** * **Arsenic Trioxide:** 0.15 mg/kg once daily intravenously (IV). * **Dimercaprol:** 2 mg/kg administered intramuscularly (IM) every 4 hours for the first 5 days, then every 6 hours for days 6-10, and then every 12 hours for days 11-21. **Consolidation and Maintenance Phases:** Dosing and schedules vary significantly. **Maximum Dose:** The maximum daily dose for Arsenic Trioxide is typically capped at 15 mg, regardless of weight. ## Pediatric Dosing Pediatric dosing is not well-established and should be based on expert consensus and institutional protocols. Extrapolation from adult doses may be necessary but requires careful consideration of growth and development. ## Dose Adjustments * **Hepatic Impairment:** Use with caution. Dose adjustments may be necessary, guided by liver function tests. * **Renal Impairment:** Use with caution. Dose adjustments may be necessary, guided by renal function tests. * **QTc Prolongation:** Dose reduction or interruption may be required if QTc interval significantly increases. * **Leukocytosis:** If leukocytosis occurs or worsens, temporary interruption of Arsenic Trioxide may be considered, sometimes with concurrent chemotherapy. ## Contraindications * Hypersensitivity to Arsenic Trioxide or Dimercaprol. * Severe hepatic or renal impairment. * Certain cardiac conditions (e.g., QTc prolongation, arrhythmias). ## Adverse Effects **Common:** * Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain. * Hematologic: Leukocytosis, neutropenia, thrombocytopenia. * Neurologic: Headache, paresthesias, encephalopathy. * Dermatologic: Rash, pruritus. * Cardiovascular: QTc prolongation, arrhythmias. * Constitutional: Fatigue, fever, edema. **Serious:** * Differentiation Syndrome (Retinoic Acid Syndrome): Fever, dyspnea, pulmonary infiltrates, pleural or pericardial effusions, hypotension. This is a medical emergency. * Hepatotoxicity. * Nephrotoxicity. * Peripheral neuropathy. * Cardiac toxicity. ## Key Drug Interactions * **QTc Prolonging Agents:** Concomitant use with other drugs that prolong the QTc interval may increase the risk of torsades de pointes. * **CYP450 Substrates:** Arsenic trioxide can inhibit CYP450 enzymes, potentially increasing concentrations of other drugs metabolized by these pathways. ## Monitoring * Complete Blood Count (CBC) with differential and platelet count. * Liver Function Tests (LFTs). * Renal Function Tests (BUN, creatinine). * Electrocardiogram (ECG) for QTc interval assessment. * Electrolytes (potassium, magnesium, calcium). * Clinical assessment for signs and symptoms of Differentiation Syndrome. ## Clinical Pearls * Differentiation Syndrome is a potentially life-threatening complication that requires prompt recognition and management, often involving dexamethasone and consideration of Arsenic Trioxide interruption. * Patients should be advised to report any new or worsening symptoms, especially fever, difficulty breathing, or swelling. * Close monitoring for QTc prolongation is crucial, especially in patients with risk factors or those taking other QTc-prolonging medications. *** **Disclaimer:** This information is intended for healthcare professionals and does not substitute for comprehensive drug information resources or clinical judgment. Always consult the most current prescribing information and relevant guidelines before making any treatment decisions.